On 23 June 2025, it was announced that people living with obesity will be able to begin accessing tirzepatide (Mounjaro®) for weight loss purposes in primary care settings. However, the national announcement on 23 June does not mean people will be able to get a prescription for tirzepatide (Mounjaro®) on this day.
Weight management services are locally commissioned at an Integrated Care Board (ICB) level, so services will differ in ICBs across the country. In mid and south Essex, access to tirzepatide will initially be through specialist weight management services only. Access to tirzepatide (Mounjaro®) through primary care is not expected to start in mid and south Essex until later in 2025.
Information about access and eligibility for patients in mid and south Essex